Header Logo

Connection

SHEKHAR GHAMANDE to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications SHEKHAR GHAMANDE has written about Antibodies, Monoclonal, Humanized.
SHEKHAR GHAMANDE
Connection Strength
0.038
Antibodies, Monoclonal, Humanized
  1. Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 2022 06 01; 205(11):1290-1299.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.